IndexGuy I think some of your numbers are off e
Post# of 148293
I think some of your numbers are off especially with the COS and all of the other costs.
If I remember right, from previous discussions the cost of LL is about $60/dose. Licensing, royalties are about 10-15%--I need to do the research to see if these are on the cost or the retail price of LL.
Retail in the $1300-1500 range. No way are the other costs going to leave us with 30% bottom line. I am guessing out bottom line is 50+%.
That being said, for COVID--I think this stock jumps to the $20 right way and then I think it is real easy to see this stock close to $100.
One of the unique things about LL is that there doesn't need to be any R & D--just trials to get it approved for other problems. That in and of itself is a HUGE savings for CYDY. While trials are expensive, R & D is really expensive and you don't always get anything back for your money that you spent.
When it did my stock price calculation a few weeks ago, if some of these other indications are approved, the stock price can just 2-5X from the $100 number.
Just my thoughts on a non-market Monday.
NJ